France
Aix-Marseille University - Etablissement Français du Sang (EFS)
transfusion, Endothelial Cells, Convalescent Plasma, COVID-19, Inflammation, Adverse Events
Convalescent plasma, COVID-19, Hematological malignancies, Anti-CD20, B-cell deficiency